Cargando…

Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes

Although advanced bladder cancer overall has a poor prognosis, a subset of patients demonstrate durable response to immune checkpoint inhibitors. Evidence shows that the response to checkpoint inhibitors may be associated with type and degree of immune infiltration in the tumor microenvironment. Her...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Huili, Zhang, Qingzhao, Shuman, Lauren, Kaag, Matthew, Raman, Jay D., Merrill, Suzanne, DeGraff, David J., Warrick, Joshua I., Chen, Guoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989654/ https://www.ncbi.nlm.nih.gov/pubmed/31996725 http://dx.doi.org/10.1038/s41598-020-58351-6

Ejemplares similares

Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS
por: Yee, Christopher H., et al.
Publicado: (2019)

Repression of transcription factor AP-2 alpha by PPARγ reveals a novel transcriptional circuit in basal-squamous bladder cancer
por: Yamashita, Hironobu, et al.
Publicado: (2019)

Characterization of Histone Deacetylase Expression Within In Vitro and In Vivo Bladder Cancer Model Systems
por: Buckwalter, Jenna M., et al.
Publicado: (2019)

FOXA1, GATA3 and PPARɣ Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines
por: Warrick, Joshua I., et al.
Publicado: (2016)

A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinoma
por: Warrick, Joshua I., et al.
Publicado: (2022)

Histologic Heterogeneity of Extirpated Renal Cell Carcinoma Specimens: Implications for Renal Mass Biopsy
por: Nahouraii, Lauren M., et al.
Publicado: (2020)

Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023
por: Joshi, Monika, et al.
Publicado: (2023)

Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer
por: Iyyanki, Tejaswi, et al.
Publicado: (2021)

Sarcopenia is a reliable predictor of outcomes following radical cystectomy for bladder cancer
por: Kaag, Matthew G., et al.
Publicado: (2018)

Intratumoral Heterogeneity Promotes Collective Cancer Invasion through NOTCH1 Variation
por: Torab, Peter, et al.
Publicado: (2021)

Perioperative chemotherapy in the management of high risk upper tract urothelial cancers
por: Kaag, Matthew G.
Publicado: (2020)

Evaluation of Therapeutic Targets in Histological Subtypes of Bladder Cancer
por: Wucherpfennig, Sophie, et al.
Publicado: (2021)

Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder
por: Tosev, Georgi, et al.
Publicado: (2021)

The dog as an animal model for bladder and urethral urothelial carcinoma: Comparative epidemiology and histology
por: de Brot, Simone, et al.
Publicado: (2018)

Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes
por: Barnes, Bethany M., et al.
Publicado: (2021)

The prognostic value of histological subtype in patients with metastatic bladder cancer
por: Chen, Cheng, et al.
Publicado: (2017)

PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer
por: Stenehjem, David D, et al.
Publicado: (2018)

microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes
por: Pardini, Barbara, et al.
Publicado: (2018)

Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma
por: Zhang, Fan, et al.
Publicado: (2022)

Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean Epithelial Ovarian Cancer Study (Ko‐EVE)
por: Sung, Soseul, et al.
Publicado: (2023)

Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer
por: Sweis, Randy F., et al.
Publicado: (2018)

Publisher Correction: Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder
por: Tosev, Georgi, et al.
Publicado: (2021)

Histological variant as the significant predictor of survival in patients with lymph node positive urothelial carcinoma of the bladder
por: Kim, Hyung Suk, et al.
Publicado: (2015)

Plasmacytoid urothelial carcinoma: a case of histological variant of urinary bladder cancer with aggressive behavior
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2014)

Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer
por: Flammia, Rocco Simone, et al.
Publicado: (2022)

Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship
por: Ramedani, Shayann, et al.
Publicado: (2021)

Identification of Immune-Related Subtypes and Construction of a Novel Prognostic Model for Bladder Urothelial Cancer
por: Zhang, Jiange, et al.
Publicado: (2022)

Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
por: Olah, Csilla, et al.
Publicado: (2022)

Identification and validation of molecular subtypes’ characteristics in bladder urothelial carcinoma based on autophagy-dependent ferroptosis
por: Liu, Shiwei, et al.
Publicado: (2023)

Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation
por: DeGraff, David J., et al.
Publicado: (2012)

Spontaneous Intraperitoneal Bladder Perforation Associated with Urothelial Carcinoma with Divergent Histologic Differentiation, Diagnosed by CT Cystography
por: Lee, Jee Han, et al.
Publicado: (2010)

Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study
por: Epaillard, Nicolas, et al.
Publicado: (2021)

A Stratified Meta-Analysis of the Association between Exposure to Environmental Tobacco Smoke during Childhood and Adulthood and Urothelial Bladder Cancer Risk
por: van Osch, Frits H. M., et al.
Publicado: (2018)

Association of histologic subtypes with genetic alteration and PD-L1 expression in pulmonary adenocarcinoma
por: Phruttinarakorn, Bantita, et al.
Publicado: (2020)

Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and in vitro validation
por: Dong, Ying, et al.
Publicado: (2023)

Do histological variants in urothelial carcinoma of the bladder portend poor prognosis? A systematic review and meta-analysis
por: Chen, Qingke, et al.
Publicado: (2017)

The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder Cancer
por: Flammia, Rocco Simone, et al.
Publicado: (2023)

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
por: Lindskrog, Sia Viborg, et al.
Publicado: (2021)

Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder
por: Hendri, Ahmad Zulfan, et al.
Publicado: (2023)

The Creative Mindset
por: DeGraff, Jeff
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m64luttbn80umativfua7aataf